A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity
← catalyst calendarNCT07437079 · readout in 155 d
Sponsored by Novo Nordisk A/S (industry) · NVO — their whole pipeline →.
Phase
Phase 1
Status
Recruiting
Study type
Interventional
Design
Randomized · Quadruple · Treatment
Enrollment
132estimated
Sites
1
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2026-02-24 | actual | When the study began enrolling |
| Primary completion | 2027-01-21 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2027-01-21 | estimated | The whole study's end, after follow-up |
| First posted | 2026-02-27 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-07-29 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Overweight
- Obesity
Interventions
- Drug: NNC6989-0001
- Drug: Placebo (NNC6989-0001)
Primary outcomes
what the primary-completion date above is the date OFNumber of treatment emergent adverse events (TEAE) - Part A
measured From time of dosing on Day1 until completion of the end of study visit (Day 7)
Number of treatment emergent adverse events (TEAE) - Part B
measured From time of dosing on Day 1 until completion of the end of study visit (Day 14)
iAUCTG; The incremental area under the blood triglycerides concentration-time curve following meal test - Part C
measured Following meal test at Day -1, Day 1, Day 7 and Day 13
Permalink · NVO's whole pipeline · Catalyst calendar · Every registered study · What changed